|Title:||Method of treating HIV infection|
|Abstract:||Disclosed is a method of treating human immunodeficiency virus (HIV) infection in an antiretroviral treatment-experienced mammal, which involves administering to the mammal an effective amount of a compound of the formula: ##STR00001## or a pharmaceutically acceptable salt, a prodrug, or an ester thereof, or a pharmaceutically acceptable composition of the compound, the salt, the prodrug, or the ester thereof, wherein A, X, Q, W, m, and R.sup.2-R.sup.6 are as defined herein.|
|Inventor(s):||Erickson; John W. (Frederick, MD), Gulnik; Sergei V. (Frederick, MD), Mitsuya; Hiroaki (Chevy Chase, MD), Ghosh; Arun K. (West Lafayette, IN)|
|Assignee:||The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) N/A (Urbana, IL) Board of Trustees of the University of Illinois (|
Patent Claim Types:|
see list of patent claims
Back Citations: 0th percentile
Forward Citations: 0th percentile
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|TABLET;ORAL||021976-004||Dec 18, 2008||RX||No||8,597,876*PED||► subscribe||Y|
|TABLET;ORAL||021976-005||Dec 18, 2008||RX||No||8,597,876*PED||► subscribe||Y|
|TABLET;ORAL||021976-001||Jun 23, 2006||DISCN||No||8,597,876*PED||► subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.